Lopicast - A Drug to Fight Coronavirus

▴ Lopicast - A Drug to Fight Coronavirus
Aprazer Healthcare (p) Ltd.is providng Lopicast - a lifesaving drug for coronavirus at affordable prices. Lopicast is having composition of Ritonavir 50 mg & Lopinavir 200 mg which are recommended to use in coronavirus cases

The endemic of coronavirus started from Wuhan city of China and is knocking the doors of different countries of the world. The deadly symptoms of Coronavirus have put many lives at risk in various regions of the world with maximum effect in Asia especially in China. Continuous attempts are been made to find cure for this virus however considering the growing number of cases doctors have decided to look for some unconventional remedies.

Lopinavir Ritonavir A drug developed to cure HIV infections is used in the treatment of Coronavirus cases. Two antiretroviral components lopinavir and ritonavir are protease inhibitors designed to block HIV viral replication. One hypothesis holds that the drugs could do the same with 2019-nCoV (Coronavirus) which is believed to have originated from the Chinese city of Wuhan.

LOPIKASTis a Generic version of Kaletra now recommended as a treatment for pneumonia caused by the new coronavirus known as 2019-nCoV China National Health Commission says in its updated clinical guidance. Wang Guangfa the leader of Peking University First Hospital pulmonary and critical care medicine department contracted the virus as a member of a national expert team dispatched to Wuhan. Lopinavir Ritonavir tabletskilled his disease Wang told state-run China News Service in areport(Chinese) recently.

In India Aprazer Healthcare Private Limited is a pharmaceutical company based at Delhi which is continuously evolving by providing lifesaving drugs at affordable prices. Aprazer Healthcare Private Limited markets LOPIKAST having composition of Ritonavir 50 mg and Lopinavir 200 mg. As this drug is recommended to use in Coronavirus cases the company has started exporting the product to China and other flu-prone regions at economical prices. The company offers reduced prices of this life-saving drug so that it is easily accessible. Announcing the measures taken by Aprazer Healthcare Pvt. Ltd. CEO of the Company Aprazer said At Aprazer our endeavour is to contribute by supplying the LOPIKAST tablets at the all-time low prices.

He further added that This drug at cost-effective prices will prove to be a stronger response to the prevailing crisis. As it a global emergency we have to face it together.Further he states that If a person is suffering from the expected symptoms of Coronavirus must visit doctor immediately. Lopikast shouldn;t be taken without recommendation and prescription of Physician. According to the doctors treating infected patients of Coronavirus the medicine is not a complete cure for the ailment. However after taking the medicine in combination with flu drug and HIV drug to an infected person the symptoms are expected to improve considerably.

Aprazer Healthcare Pvt. Ltd. has already begun to supply LOPIKAST tablets in the hospitals and cure centres across China. Coronavirus outbreak in China is screaming for assistance from all over the world. The sensitive approach of Aprazers is what other companies should replicate as rightly quoted by Mr. Gandhi. Sometimes profit is not a consideration.

Tags : #Coronavirus #Aprazerhealthcare #Lopicast #Healthcare

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Exploring Mortality Risks for Lesbian and Bisexual Women: Key Findings from a Comprehensive Research EffortApril 29, 2024
Implications of Alcohol Intake During Pregnancy on Fetal Development: New Study Reveals Subtle ChangesApril 29, 2024
Indian Air Force's Night Vision Rescue: Soldier’s Life Saved in High-Stakes AirliftApril 29, 2024
Now You Can Also Buy Insurance For Your Parents Aged Above 65 years: IRDAI Lifts Age Cap for Health Insurance Expanding Healthcare AccessApril 29, 2024
Ensuring Infection Control: Central Government Hospitals Implement New Safety MeasuresApril 29, 2024
Dish TV Revolutionizes Entertainment with ‘Dish TV Smart+’ Services, Offering TV and OTT on Any Screen, AnywhereApril 26, 2024
Arohan Financial Services Recognized Among India's Best Workplaces in BFSI 2024April 26, 2024
Why Podcasts Are the Next Big Thing in Healthcare Advertising in IndiaApril 26, 2024
Challenges of Child Growth at High Altitudes: New Study Reveals ImpactApril 26, 2024
Staying Cool in India's Scorching Heat: Heatwave Safety TipsApril 26, 2024
The Dark Side of Neotame (Artificial Sweetener): New Research Raises Concerns about Gut HealthApril 26, 2024
Sightsavers India Fellowship Program Invites Applications for Promising OphthalmologistsApril 25, 2024
Transforming Brain Healthcare: India's Visionary Task Force for Neurological DisordersApril 25, 2024
The Battle Against Malaria: Rising Trends and Vaccine InnovationsApril 25, 2024
Talc and Asbestos Controversy: Inside Johnson & Johnson's Courtroom StruggleApril 25, 2024
The Hidden Struggles of Parenthood: Addressing Isolation, Loneliness, and BurnoutApril 25, 2024
FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024